Organometallic Compounds: Synthesis and Biological Activity

Dear Colleagues,

Organometallic compounds are important as homogeneous catalysts for the production of pharmaceuticals, among many other products. However, since the reports of the first organometallic chemotherapeutic agent, salvarsan, by Paul Ehrlich (1854–1915, Nobel Prize in Physiology or Medicine in 1908), it has been realized that they can also play an important role as biologically active compounds in the design of novel pharmaceuticals. While only a few organometallic complexes that contain at least one direct metal-carbon bond occur in nature, such as vitamin B₁₂ and some iron and nickel hydrogenases, many organometallic complexes have been studied for biological and medicinal applications. This Special Issue will collect the most recent contributions on the synthesis and biological activities of organometallic complexes in the treatment of viral, fungal, bacterial, and parasitic infections, as well as in the diagnosis and treatment of cancer (also as theranostics), as NO- or CO-releasing molecules, radiopharmaceuticals or for bioanalytical applications.

Prof. Dr. Evamarie Hey-Hawkins
Prof. Dr. Santiago Gómez-Ruiz
Prof. Dr. Goran Kaluđerović
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.